AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Insuglo M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Neiss Labs Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Insuglo M 2mg/500mg Tablet SR

Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.

Primary Ingredients of Insuglo M 2mg/500mg Tablet SR

No text provided. Please provide the text you want me to rephrase.

Uses of Insuglo M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Insuglo M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Insuglo M 2mg/500mg Sustained-Release Tablet should be taken with a meal.

Common Side effects of Insuglo M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Insuglo M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Insuglo M 2mg/500mg Extended-Release tablets with food.

How Insuglo M 2mg/500mg Tablet SR works:

Insuglo M SR tablets (2mg/500mg) combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose levels. Metformin works via three mechanisms: decreased hepatic glucose production, slowed intestinal glucose absorption, and enhanced insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Insuglo M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Insuglo M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Insuglo M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Insuglo M 2mg/500mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Insuglo M 2mg/500mg SR tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver disease should use Insuglo M 2mg/500mg SR tablets cautiously, as dose modification may be necessary. Consult your physician. For those with mild to moderate liver impairment, Insuglo M 2mg/500mg SR tablets are typically initiated at a low dosage; however, their use is contraindicated in individuals with severe liver disease.

What if you forget to take Insuglo M 2mg/500mg Tablet SR :

Should you forget a dose of Insuglo M 2mg/500mg SR tablets, administer it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Insuglo M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Insuglo M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Insuglo M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Insuglo M 2mg/500mg Tablet SR and seek immediate medical attention.
Insuglo M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Insuglo M 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Insuglo M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Insuglo M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Insuglo M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Insuglo M 2mg/500mg Table...
40
MRP 46
13% off